Remove topics petitioner-reply-briefs
article thumbnail

Federal Circuit Rules on Inventor-as-Lexicographer Definitions and the Proper Scope of Reply and Sur-Reply Briefing Following Patent Owner Responses to IPR Institution Decisions

Intellectual Property Law Blog

Intel filed a reply arguing that the ’551 Patent did not restrict a “storage element” to being part of an energy transfer system, and therefore prior art Tayloe taught “storage elements” because Tayloe’s capacitors stored a non-negligible amount of energy. Vidal, Under Secretary of Commerce for IP and USPTO Director No. 2022-1548, (Fed.

Inventor 130
article thumbnail

Federal Circuit Rules on Inventor-as-Lexicographer Definitions and the Proper Scope of Reply and Sur-Reply Briefing Following Patent Owner Responses to IPR Institution Decisions

LexBlog IP

Intel filed a reply arguing that the ’551 Patent did not restrict a “storage element” to being part of an energy transfer system, and therefore prior art Tayloe taught “storage elements” because Tayloe’s capacitors stored a non-negligible amount of energy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2021 Post-Grant Report

Fish & Richardson Trademark & Copyright Thoughts

Likewise, as with rehearing, the interim procedures do not reserve briefing for the non-requesting party. 1, 2020) , Petitioner Sotera petitioned for IPR nearly twelve months after Patent Owner Masimo filed a patent infringement suit against Sotera in the Southern District of California. Back to Top. Sotera Wireless, Inc.

article thumbnail

Does Transformative Matter? No, At Least Where Use Is Commercial

LexBlog IP

These were the hot topics in the recently decided Supreme Court case of Andy Warhol Foundation for the Visual Arts, Inc. ” Brief For Petitioner at 19 (June 10, 2022). ” Reply Brief For Petitioner at 1 (dated September 7, 2022). Andy Warhol. And Prince, the Purple One. (Or Or in this case, Orange.)

article thumbnail

Biosimilars 2021 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., Hospira and Pfizer, in reply, contested Amgen’s positions. (